Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial-Reference-Cited by-同舟云学术

Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial

Published:2024-07 Issue:4 Volume:42 Page:
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Suo Xiaohui¹,Fang Zheng²,Wang Dongmei³,Zhao Liyun⁴,Liu Jie⁵,Li Hong⁶,Ma Xiaojun¹,Zhang Congcong¹,Zhao Xuemei²,Shi Rui³,Wu Yan³,Jiao Zongjiu⁴,Song Jiaojie⁴,Zhang Ling⁵,Li Ling⁷,Zhang Suping⁸,Lu Xinxiao⁹,Yuan Linyu⁹^ORCID,Gao Sifeng¹⁰,Zhang Jilei¹⁰,Liu Kaiqi¹¹^ORCID,Zhao Xingli⁹,Bai Guanchen¹⁰,Mi Yingchang¹¹

Affiliation:

1. Department of Hematology Handan Central Hospital Handan Hebei China

2. Department of Hematology The Second People's Hospital of Guiyang Guiyang Guizhou China

3. Department of Hematology Harrison International Peace Hospital Hengshui Hebei China

4. Department of Hematology People Hospital of XingTai Xing Tai Hebei China

5. Department of Hematology Sinopharm Tongmei General Hospital Datong Shanxi China

6. Department of Hematology Daqing Oilfied General Hospital Daqing Heilongjiang China

7. Department of Hematology Inner Mongolia People's Hospital Huhehaote Neimenggu China

8. Department of Hematology The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

9. Department of Hematology Oncology Center Tianjin People's Hospital Tianjin China

10. Department of Hematology The Affiliated Tai'an City Central Hospital of Qingdao University Taian Shandong China

11. State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3296

Reference5 articles.

1. Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy

2. Venetoclax combined with FLAG‐IDA induction and consolidation in newly diagnosed acute myeloid leukemia